Alex Rodriguez TRT: What a Celebrity Pays vs. A Regular Patient

The Biogenesis Scandal: What Rodriguez Actually Used

The records obtained from the Biogenesis of America clinic in Coral Gables, Florida, list Rodriguez as a client who received testosterone, human growth hormone, and insulin-like growth factor-1 (IGF-1) between 2010 and 2012. That is not a rumor. Those records were authenticated in MLB arbitration proceedings that ended in a 162-game suspension in January 2014.

Testosterone and IGF-1: What the Clinic Records Show

Rodriguez had previously admitted to using testosterone and a substance called "Primobolan" (methenolone) from 2001-2003 while playing for the Texas Rangers, in a 2009 interview with ESPN. He described obtaining it from his cousin in the Dominican Republic. Methenolone is an anabolic-androgenic steroid that is Schedule III controlled in the United States under the Controlled Substances Act [1].

The Biogenesis records, as reported by the Miami New Times and later confirmed in the MLB arbitration record, included testosterone cream and injectable testosterone. IGF-1 is not a controlled substance but is banned under both MLB's Joint Drug Prevention and Treatment Program and the World Anti-Doping Agency (WADA) prohibited list [2].

Why IGF-1 Is Clinically Relevant

IGF-1 is produced primarily in the liver in response to growth hormone. Exogenous IGF-1 administration can suppress endogenous GH secretion through negative feedback. A 2013 paper in the Journal of Clinical Endocrinology and Metabolism found that supraphysiologic IGF-1 administration raised serum IGF-1 to levels above 400 ng/mL in healthy men, well above the adult reference range of 88-246 ng/mL [3]. At those concentrations, soft-tissue growth, fluid retention, and insulin resistance are documented adverse effects.

The Arbitration Outcome

Commissioner Bud Selig's original suspension was 211 games. Arbitrator Fredric Horowitz reduced it to 162 games, which covered all of the 2014 season. Rodriguez forfeited approximately $25 million in salary. The arbitration ruling itself noted that Rodriguez had "received performance-enhancing substances" and had "obstructed the investigation."

What Legitimate TRT Actually Is

Testosterone replacement therapy, when properly prescribed, addresses clinically confirmed hypogonadism: a condition defined by the Endocrine Society as serum total testosterone below 300 ng/dL on two morning measurements, combined with symptoms such as low libido, fatigue, reduced muscle mass, or depressed mood [4].

Diagnosis Requirements

The 2018 Endocrine Society Clinical Practice Guideline recommends confirming hypogonadism with:

• Two fasting morning total testosterone measurements (before 10 AM)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to classify primary vs. Secondary hypogonadism
• Prolactin if secondary hypogonadism is suspected
• Complete blood count (CBC) to screen for polycythemia before initiating therapy

The guideline states directly: "We recommend against a general policy of offering TRT to all older men with low testosterone." Symptoms plus biochemical confirmation are both required [4].

FDA-Approved Testosterone Formulations

The FDA has approved multiple testosterone delivery systems [5]:

• Testosterone cypionate injection (Depo-Testosterone): 100-200 mg IM every 7-14 days
• Testosterone enanthate injection: 50-400 mg IM every 2-4 weeks
• Testosterone undecanoate injection (Aveed): 750 mg IM, then 750 mg at 4 weeks, then every 10 weeks
• Transdermal gel (AndroGel 1%, 1.62%; Testim; Vogelxo): 40.5-81 mg daily
• Intranasal gel (Natesto): 11 mg three times daily
• Subcutaneous pellets (Testopel): 150-450 mg every 3-6 months

None of these formulations is a performance-enhancing drug when used at physiologic replacement doses targeting 400-700 ng/dL serum total testosterone, which is mid-normal for adult men [4].

Celebrity TRT Programs vs. Standard Telehealth: The Real Cost Breakdown

Cost is where the celebrity experience diverges most sharply from a typical patient's experience. The molecules are often identical. The price difference comes from access, convenience, and add-on services.

Standard Telehealth TRT Pricing

A standard telehealth TRT program typically includes:

• Initial online consultation: $0-$99 (often waived)
• Monthly medication cost (testosterone cypionate, generic): $40-$80 for a 10 mL multi-dose vial
• Monthly platform or membership fee: $75-$200
• Quarterly labs (total testosterone, hematocrit, PSA, LH, estradiol): $60-$150 per draw
• Total monthly all-in cost: $150-$400

Testosterone cypionate is available as a generic at many pharmacies for under $50 per 10 mL vial, which at 100 mg per week lasts approximately 10 weeks [5]. That is the same active molecule a celebrity uses.

Celebrity Concierge TRT Pricing

A high-end concierge men's health program serving professional athletes and executives typically bundles:

• Physician house calls or private clinic visits: $500-$1,500 per visit
• Compounded testosterone formulations (custom concentrations, cream, troches, subq pellets): $200-$600 per month
• Add-on peptides such as sermorelin, ipamorelin, or BPC-157: $200-$500 per month each
• Comprehensive quarterly bloodwork panels (40-60 biomarkers): $400-$1,200 per draw
• Continuous glucose monitoring, DEXA body composition scans, VO2 max testing: $300-$800 per quarter
• Concierge coordination and 24/7 physician access: $500-$2,000 per month retainer
• Total monthly all-in cost: $2,000-$8,000 or more

The Biogenesis clinic charged Rodriguez a reported $12,000 for a single course of substances, according to the Miami New Times reporting. That figure was not for FDA-approved TRT. It included substances whose clinical use outside of specific diagnosed conditions lacks regulatory approval.

What You Are Actually Paying For

The price gap is not about drug quality. Generic testosterone cypionate manufactured by Pfizer or Hikma and dispensed through a retail pharmacy meets the same USP standards as any compounded product [5]. What the premium buys is:

• Same-day or next-day appointments
• Physician availability by text or phone
• Custom compounding for non-standard concentrations
• Coordination across multiple providers (endocrinologist, cardiologist, sports medicine)
• Discretion. For a public figure, discretion has measurable economic value.

A 2021 analysis in JAMA Internal Medicine found that concierge medicine patients paid an average of $2,640 per year in retainer fees alone, above their standard insurance or cash-pay costs, primarily for access rather than clinical outcomes [6].

The Physiology Rodriguez Was Manipulating

Understanding why supraphysiologic testosterone was appealing to a power hitter requires a basic look at what pharmacologic doses actually do to muscle physiology.

Skeletal Muscle and the Androgen Receptor

Testosterone binds androgen receptors in skeletal muscle, increasing nitrogen retention and stimulating satellite cell proliferation, which accelerates myofibrillar protein synthesis. A landmark 1996 NEJM study by Bhasin et al. (N=43) showed that men receiving 600 mg testosterone enanthate per week for 10 weeks gained 6.1 kg of fat-free mass vs. 1.9 kg in the placebo-plus-exercise group, without any additional training [7]. Rodriguez was a strength athlete. That differential in lean mass directly translates to bat speed and power output.

The Hematocrit Effect

Testosterone also stimulates erythropoiesis via increased erythropoietin production in the kidneys. Elevated red blood cell mass improves oxygen delivery to working muscle. The Endocrine Society guideline recommends monitoring hematocrit because values above 54% significantly increase thrombotic risk [4]. MLB's drug testing program screens for this marker as part of its carbon isotope ratio (CIR) testing for synthetic testosterone.

Why 200 mg/Week Is Therapeutic but 400-600 mg/Week Is Pharmacologic

At 100-200 mg testosterone cypionate per week, serum total testosterone typically reaches 600-900 ng/dL at peak (24-48 hours post-injection) and 300-500 ng/dL at trough (day 6-7). That is physiologic replacement [4]. At 400-600 mg per week, peak testosterone may reach 2,000-4,000 ng/dL, a level associated with the muscle gains documented in the Bhasin trial [7]. The Biogenesis-era athlete was not pursuing replacement. The target was supraphysiologic enhancement.

Monitoring: What Safe TRT Actually Requires

The gap between celebrity abuse and legitimate TRT is most visible in monitoring. A properly managed patient has regular lab checks that would catch dangerous deviations. An athlete seeking performance enhancement avoids those checks.

Recommended Lab Monitoring Schedule

Per the 2018 Endocrine Society guideline [4]:

• 3 months after initiation: total testosterone (mid-cycle for injections), hematocrit, PSA
• 12 months: full panel including LH, FSH, lipid panel, liver enzymes, bone density (if osteoporosis risk present)
• Annually thereafter: same panel

A hematocrit above 54% requires dose reduction or temporary discontinuation. A PSA rise of more than 1.4 ng/mL in any 12-month period, or a PSA above 4.0 ng/mL, requires urology referral [4].

What Telehealth Platforms Actually Check

Reputable telehealth TRT platforms (those compliant with state medical board requirements) require labs before prescribing and recheck every 90-180 days. Platforms that prescribe without any baseline labs are operating outside standard of care. The FDA's guidance on testosterone products specifies that prescribers should confirm low testosterone with lab testing before initiating treatment [5].

The Risk of Unmonitored Use

A 2023 cohort study in the Journal of the American College of Cardiology (N=5,460 men on TRT, followed median 3.4 years) found that men who maintained hematocrit above 52% had a 2.3-fold higher rate of venous thromboembolism compared to those with hematocrit 40-48% [8]. Supraphysiologic dosing without monitoring is not a celebrity luxury. It is a documented cardiovascular hazard.

Peptides: The Add-On That Inflates Both the Bill and the Risk

The Biogenesis records included peptide hormones alongside testosterone. Peptides have become a standard upsell in concierge men's health programs and deserve a separate look.

Sermorelin and Ipamorelin

Sermorelin is a growth hormone-releasing hormone (GHRH) analogue. Ipamorelin is a growth hormone secretagogue. Both stimulate pituitary GH secretion rather than providing exogenous GH directly. The FDA approved sermorelin acetate (Geref) for pediatric GH deficiency but withdrew the NDA holder's marketing application in 2008; compounded sermorelin has continued through 503A pharmacies [9].

A 2019 Cochrane systematic review of growth hormone secretagogues in healthy older adults found modest increases in lean body mass (mean difference 1.1 kg) but no significant improvements in physical function or quality of life, with increased rates of peripheral edema and arthralgias [10].

BPC-157

BPC-157 (body protection compound-157) is a synthetic peptide derived from a human gastric protein. It has no FDA approval for any indication. All human data are limited to case reports and small open-label series. The FDA issued a safety alert in 2022 advising consumers that BPC-157 products are not FDA-approved and that safety and efficacy data are insufficient [9]. A concierge program charging $300-$500 per month for BPC-157 is selling a product whose risk-benefit profile has not been established in randomized controlled trials.

What Rodriguez's Case Teaches a Regular Patient

Rodriguez's trajectory illustrates three failure modes that any patient considering hormone therapy should recognize.

Failure Mode 1: No Baseline Diagnosis

Rodriguez did not report symptoms of hypogonadism or pursue a medical diagnosis before using testosterone. He used testosterone as an ergogenic aid. A legitimate TRT patient starts with a documented testosterone level below 300 ng/dL and symptoms. Starting without a diagnosis bypasses the clinical gatekeeping that prevents adverse events.

Failure Mode 2: Supraphysiologic Dosing Without Monitoring

The performance-enhancement doses used at Biogenesis were multiples of physiologic replacement doses. Without hematocrit monitoring, thrombotic risk accumulates silently. Without PSA monitoring, prostate pathology goes undetected. The 162-game suspension was the least medically consequential penalty.

Failure Mode 3: Unregulated Add-Ons

IGF-1, growth hormone, and unapproved peptides were layered onto testosterone. Each additional agent multiplies pharmacokinetic interactions and adverse-effect profiles. The Endocrine Society guideline explicitly states that IGF-1 should not be used as a surrogate marker for GH adequacy and that GH therapy in adults without documented GH deficiency is not recommended [4].

Is There Any Scenario Where Rodriguez's Current TRT Use Would Be Legitimate?

Rodriguez is 49 years old as of 2025. Age-related decline in testosterone, sometimes called late-onset hypogonadism, is real and documented. A 2007 analysis of the Massachusetts Male Aging Study found that total testosterone declined approximately 1.6% per year in men aged 45-79 [11]. A man who tested at 600 ng/dL at age 30 may test at 380-420 ng/dL at age 49, which remains in the normal range but could be accompanied by symptoms.

If Rodriguez's serum total testosterone on two morning measurements is below 300 ng/dL and he has qualifying symptoms, legitimate TRT is both medically appropriate and legal. The cost at that point is $150-$400 per month at a telehealth clinic. He does not need a $6,000 concierge package. He needs the same testosterone cypionate prescription available to any patient with confirmed hypogonadism.

The Endocrine Society guideline recommends starting with testosterone cypionate or enanthate 75-100 mg IM weekly, or 150-200 mg every two weeks, with a dose titration at 3 months based on mid-cycle serum testosterone [4]. That protocol costs roughly $50-$80 in medication per month.